Emergent Biosolutions, Inc. (EBS): Price and Financial Metrics

EBS POWR Grades

• Growth is the dimension where EBS ranks best; there it ranks ahead of 95.25% of US stocks.
• EBS's strongest trending metric is Growth; it's been moving up over the last 177 days.
• EBS's current lowest rank is in the Sentiment metric (where it is better than 0.08% of US stocks).

EBS Stock Summary

• With a one year PEG ratio of 0.05, EMERGENT BIOSOLUTIONS INC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than just 1.17% of US stocks.
• EBS's price/sales ratio is 0.12; that's higher than the P/S ratio of merely 3.02% of US stocks.
• In terms of twelve month growth in earnings before interest and taxes, EMERGENT BIOSOLUTIONS INC is reporting a growth rate of -383.53%; that's higher than just 3.66% of US stocks.
• Stocks that are quantitatively similar to EBS, based on their financial statements, market capitalization, and price volatility, are TELL, FA, VMAR, KN, and RCAT.
• Visit EBS's SEC page to see the company's official filings. To visit the company's web site, go to www.emergentbiosolutions.com.

EBS Valuation Summary

• EBS's price/earnings ratio is -0.2; this is 100.75% lower than that of the median Healthcare stock.
• EBS's price/sales ratio has moved down 2.8 over the prior 207 months.

Below are key valuation metrics over time for EBS.

EBS Growth Metrics

Its 3 year cash and equivalents growth rate is now at 217.32%.
• The 2 year cash and equivalents growth rate now stands at 139.96%.
• Its 4 year revenue growth rate is now at 115.98%.

EBS's revenue has moved up $807,924,000 over the prior 49 months.

The table below shows EBS's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	1,513.4	202.1	53.5
2022-06-30	1,602.4	292.8	96.5
2022-03-31	1,757.2	278.7	157.5
2021-12-31	1,792.7	321.1	230.9
2021-09-30	1,652.5	237.2	227
2021-06-30	1,708.7	325.7	299.2

EBS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• EBS has a Quality Grade of C, ranking ahead of 50.38% of graded US stocks.
• EBS's asset turnover comes in at 0.604 -- ranking 57th of 681 Pharmaceutical Products stocks.
• ARWR, IBIO, and MCRB are the stocks whose asset turnover ratios are most correlated with EBS.

The table below shows EBS's key quality metrics over time.